About Intarcia Therapeutics, Inc.
We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking.
We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved.
We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases.
Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine.
|
|
|
51-200 employees
View all Intarcia Therapeutics, Inc. employees
|
|
Biotechnology Research
|
|
$10M–$50M
|
|
(617) 500-1000
|
|
One Marina Park Drive, Suite 1300, Boston, MA 02210, US
|
|
1997
|
Intarcia Therapeutics, Inc. Alternatives
Frequently Asked Questions about Intarcia Therapeutics, Inc.
The decision makers in Intarcia Therapeutics, Inc. are Ajay Mohite, Corliss Low, Debra Platek, etc. Click to Find Intarcia Therapeutics, Inc. decision makers emails.
Intarcia Therapeutics, Inc. headquarters is located at One Marina Park Drive, Suite 1300, Boston, MA 02210, US.
Intarcia Therapeutics, Inc. generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Intarcia Therapeutics, Inc. by calling (617) 500-1000.
Intarcia Therapeutics, Inc. Staff Directory
Search Intarcia Therapeutics, Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
